TITLE:
A Study to Evaluate Denosumab in the Treatment of Postmenopausal Osteoporosis

CONDITION:
Osteoporosis

INTERVENTION:
placebo

SUMMARY:

      This study will evaluate the effectiveness and safety of denosumab in treating women with
      Postmenopausal Osteoporosis.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 60 Years to 90 Years
Criteria:

        Inclusion Criteria:

          -  Women who are 60 to 90 years of age may be eligible to participate

          -  Bone mineral density (BMD) T-Score at hip or spine must be less than -2.5

        Exclusion Criteria:

          -  BMD T-Score at the hip or the spine of less than -4.0

          -  Patients with any severe or more than two moderate vertebral fractures on spinal
             x-ray at entry
      
